The European Union’s proposed restriction on per- and polyfluoralkyl substances (PFAS) could eliminate medical devices required for minimally invasive surgeries, among many others, to the detriment of millions of patients, according to MedTech Europe.
EU’s Historic PFAS Restriction Looms Over Medical Devices Sector
The European Chemicals Agency’s committees for Risk Assessment (RAC) and Socio-Economic Analysis (SEAC) are evaluating sector by sector the proposed REACH restriction on PFAS and more than 5,600 public comments, reaching provisional conclusions on cosmetics at their June meetings. A date has not been set to consider PFAS uses in medical devices, which are numerous, essential, and in many cases devoid of alternatives, industry says.
